Chunbing Chen - Search Results

Year	Number of Results
2015	1
2016	3
2017	6
2018	10
2019	11
2020	12
2021	21
2022	24
2023	24
2024	9

1

JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.

Huang IH, Chung WH, Wu PC, Chen CB. Huang IH, et al. Front Immunol. 2022 Dec 8;13:1068260. doi: 10.3389/fimmu.2022.1068260. eCollection 2022. Front Immunol. 2022. PMID: 36569854 Free PMC article. Review.

2

An updated review of the immunological mechanisms of keloid scars.

Lee CC, Tsai CH, Chen CH, Yeh YC, Chung WH, Chen CB. Lee CC, et al. Front Immunol. 2023 Mar 22;14:1117630. doi: 10.3389/fimmu.2023.1117630. eCollection 2023. Front Immunol. 2023. PMID: 37033989 Free PMC article. Review.

3

Eczema coxsackium.

Su HJ, Chen CB. Su HJ, et al. Med J Aust. 2021 Nov 1;215(9):403. doi: 10.5694/mja2.51297. Epub 2021 Oct 10. Med J Aust. 2021. PMID: 34632588 No abstract available.

4

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Wang CW, Yang LY, Chen CB, Ho HC, Hung SI, Yang CH, Chang CJ, Su SC, Hui RC, Chin SW, Huang LF, Lin YY, Chang WY, Fan WL, Yang CY, Ho JC, Chang YC, Lu CW, Chung WH; the Taiwan Severe Cutaneous Adverse Reaction (TSCAR) Consortium. Wang CW, et al. J Clin Invest. 2018 Mar 1;128(3):985-996. doi: 10.1172/JCI93349. Epub 2018 Feb 5. J Clin Invest. 2018. PMID: 29400697 Free PMC article. Clinical Trial.

5

Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.

Zhang J, Lu CW, Chen CB, Wang CW, Chen WT, Cheng B, Ji C, Chung WH. Zhang J, et al. J Allergy Clin Immunol Pract. 2022 May;10(5):1295-1304.e6. doi: 10.1016/j.jaip.2022.01.038. Epub 2022 Feb 4. J Allergy Clin Immunol Pract. 2022. PMID: 35131514

6

Genetics of Severe Cutaneous Adverse Reactions.

Yang SC, Chen CB, Lin MY, Zhang ZY, Jia XY, Huang M, Zou YF, Chung WH. Yang SC, et al. Front Med (Lausanne). 2021 Jul 15;8:652091. doi: 10.3389/fmed.2021.652091. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34336873 Free PMC article. Review.

7

Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.

Wang CY, Wang CW, Chen CB, Chen WT, Chang YC, Hui RC, Chung WH. Wang CY, et al. Int J Mol Sci. 2023 Apr 15;24(8):7329. doi: 10.3390/ijms24087329. Int J Mol Sci. 2023. PMID: 37108492 Free PMC article. Review.

8

Periorbital purpura following intense emesis.

Hung YT, Chen CB. Hung YT, et al. Med J Aust. 2022 May 16;216(9):454. doi: 10.5694/mja2.51504. Epub 2022 Apr 14. Med J Aust. 2022. PMID: 35421901 No abstract available.

9

Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.

Chen HC, Wang CW, Toh WH, Lee HE, Chung WH, Chen CB. Chen HC, et al. Clin Rev Allergy Immunol. 2023 Dec;65(3):331-353. doi: 10.1007/s12016-023-08973-1. Epub 2023 Oct 28. Clin Rev Allergy Immunol. 2023. PMID: 37897588 Review.

10

Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches.

Toh WH, Lee HE, Chen CB. Toh WH, et al. Front Med (Lausanne). 2023 Aug 8;10:1196946. doi: 10.3389/fmed.2023.1196946. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37614956 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year